Sun Isles Beach, Fla (PRWEB) December 05, 2016
Physicians Education Resource®, LLC (PER®) announces Amy E. Herman as Keynote speaker for the 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February 24, 2017.
In making the announcement, PER® president, Phil Talamo said, “We are honored to have Amy E. Herman present at this year’s conference, her unprecedented knowledge conducting leadership training will provide attendees with added expertise to lead future medical teams, which is vital to improving the lives of cancer patients in such a fast-moving field.”
With over 14 years of experience, Herman is the founder and president of The Art of Perception, Inc., and a leading expert in professional development, training some of the most influential industry leaders around the world, including the FBI, CIA, Scotland Yard, and the Peace Corps. Prior to this, Herman was the director of the educational development for the public television station, serving New Jersey and New York, Thirteen/WNET.
In addition, the co-chairs for this year’s conference are Andre Goy, MD, MS, and Sagar Lonial, MD, FACP. Dr. Goy is the chairman and director of the John Theurer Cancer Center and the chief of the division of lymphoma. Dr. Lonial is the chief medical officer for the Winship Cancer Institute of Emory University and a board-certified hematologist and medical oncologist.
The 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma is a three-day educational symposium from February 23rd-25th at the Trump International Miami. To register for the symposium, visit: http://www.gotoper.com
Since 1995, PER® has been the educational resource of choice for live and online activities focusing on oncology and hematology. PER® provides high-quality, evidence-based activities featuring leading national and international faculty with a focus on practice-changing advances and standards of care in treatment and disease management. Activities also include topics on emerging strategies currently under investigation, supportive care, diagnosis and staging, prevention, screening and early detection, and practice management. With the rapid advances occurring in the field of oncology, understanding how to use molecular data to diagnose and stage patients, selecting the most appropriate candidates for novel therapeutic agents, individualizing treatment based on tumor type, and referring patients to clinical trials will continue to ensure the highest level of patient care is provided. PER® serves the oncology health care community, including physicians, fellows, advanced practice nurses, nurses, physician assistants, pharmacists, and researchers. PER® is part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com
Read the full story at http://www.prweb.com/releases/2016/12/prweb13897649.htm.
Copyright©2016 Vocus, Inc.
All rights reserved